Stephen Sanders

Array ( [id] => 9370327 [patent_doc_number] => 20140080200 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-03-20 [patent_title] => 'METHODS OF PURIFYING POLYPEPTIDES' [patent_app_type] => utility [patent_app_number] => 13/516740 [patent_app_country] => US [patent_app_date] => 2010-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 20499 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13516740 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5959504 [patent_doc_number] => 20110183891 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-28 [patent_title] => 'Methods and Compositions for Inhibiting Fungal Infection and Disease' [patent_app_type] => utility [patent_app_number] => 12/967896 [patent_app_country] => US [patent_app_date] => 2010-12-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 16027 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0183/20110183891.pdf [firstpage_image] =>[orig_patent_app_number] => 12967896 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8510265 [patent_doc_number] => 20120309673 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-12-06 [patent_title] => 'CYSTEINE PROTEASE INHIBITORS' [patent_app_type] => utility [patent_app_number] => 13/514758 [patent_app_country] => US [patent_app_date] => 2010-12-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23003 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13514758 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9318435 [patent_doc_number] => 20140050773 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-02-20 [patent_title] => 'COMPOUND COMPRISING ALPHA-MSH FOR USE IN ENDODONTIC REGENERATION' [patent_app_type] => utility [patent_app_number] => 13/990004 [patent_app_country] => US [patent_app_date] => 2010-11-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 11807 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13990004 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8431134 [patent_doc_number] => 20120253009 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-10-04 [patent_title] => 'THROMBOPOIETIC COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 13/502107 [patent_app_country] => US [patent_app_date] => 2010-10-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29182 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13502107 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10148951 [patent_doc_number] => 09181224 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-11-10 [patent_title] => 'Bifunctional molecules with antibody-recruiting and entry inhibitory activity against the human immunodeficiency virus' [patent_app_type] => utility [patent_app_number] => 13/501592 [patent_app_country] => US [patent_app_date] => 2010-10-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 16 [patent_no_of_words] => 28508 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13501592 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7807977 [patent_doc_number] => 20120058931 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-08 [patent_title] => 'Drug target that promotes secretory granule-granule fusion' [patent_app_type] => utility [patent_app_number] => 12/796035 [patent_app_country] => US [patent_app_date] => 2010-09-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 1215 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0058/20120058931.pdf [firstpage_image] =>[orig_patent_app_number] => 12796035 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6186224 [patent_doc_number] => 20110124564 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-26 [patent_title] => 'NUCLEOLIN-BINDING PEPTIDES, NUCLEOLIN- BINDING LYTIC PEPTIDES, FUSION CONSTRUCTS AND METHODS OF MAKING AND USING SAME' [patent_app_type] => utility [patent_app_number] => 12/868353 [patent_app_country] => US [patent_app_date] => 2010-08-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 28010 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0124/20110124564.pdf [firstpage_image] =>[orig_patent_app_number] => 12868353 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8452756 [patent_doc_number] => 20120263701 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-10-18 [patent_title] => 'COAGULATION FACTOR VII COMPOSITIONS AND METHODS OF MAKING AND USING SAME' [patent_app_type] => utility [patent_app_number] => 13/392509 [patent_app_country] => US [patent_app_date] => 2010-08-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 37 [patent_figures_cnt] => 37 [patent_no_of_words] => 93792 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 19 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13392509 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10019829 [patent_doc_number] => 09062299 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-06-23 [patent_title] => 'Coagulation factor IX compositions and methods of making and using same' [patent_app_type] => utility [patent_app_number] => 13/392511 [patent_app_country] => US [patent_app_date] => 2010-08-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 36 [patent_figures_cnt] => 36 [patent_no_of_words] => 95232 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13392511 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8253059 [patent_doc_number] => 20120157385 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-06-21 [patent_title] => 'CYCLOSPORIN CONJUGATES' [patent_app_type] => utility [patent_app_number] => 13/386317 [patent_app_country] => US [patent_app_date] => 2010-07-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 14503 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0157/20120157385.pdf [firstpage_image] =>[orig_patent_app_number] => 13386317 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8199294 [patent_doc_number] => 20120122787 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-17 [patent_title] => 'METHODS FOR TREATING POLYCYSTIC KIDNEY DISEASE (PKD) OR OTHER CYST FORMING DISEASES' [patent_app_type] => utility [patent_app_number] => 13/382978 [patent_app_country] => US [patent_app_date] => 2010-07-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 36 [patent_figures_cnt] => 36 [patent_no_of_words] => 21890 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0122/20120122787.pdf [firstpage_image] =>[orig_patent_app_number] => 13382978 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8278432 [patent_doc_number] => 20120172302 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-07-05 [patent_title] => 'COMPOSITION FOR THE TREATMENT OF BENIGN PROSTATE HYPERPLASIA' [patent_app_type] => utility [patent_app_number] => 13/381762 [patent_app_country] => US [patent_app_date] => 2010-07-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 9564 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13381762 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7484212 [patent_doc_number] => 20110250132 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-13 [patent_title] => 'LIPOIC ACID METABOLITE: USEFUL FOR DRUG CARRIER, NANOPARTICLE CONJUGATE, IMAGING AND HYPERTHERMIA THERAPY' [patent_app_type] => utility [patent_app_number] => 12/826465 [patent_app_country] => US [patent_app_date] => 2010-06-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 7877 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0250/20110250132.pdf [firstpage_image] =>[orig_patent_app_number] => 12826465 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6391992 [patent_doc_number] => 20100318120 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-16 [patent_title] => 'HEMOSTATIC MATERIAL AND DELIVERY DEVICE' [patent_app_type] => utility [patent_app_number] => 12/815589 [patent_app_country] => US [patent_app_date] => 2010-06-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 7882 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0318/20100318120.pdf [firstpage_image] =>[orig_patent_app_number] => 12815589 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9427644 [patent_doc_number] => 08703717 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-04-22 [patent_title] => 'Growth hormone polypeptides and methods of making and using same' [patent_app_type] => utility [patent_app_number] => 12/796640 [patent_app_country] => US [patent_app_date] => 2010-06-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 38 [patent_figures_cnt] => 37 [patent_no_of_words] => 86581 [patent_no_of_claims] => 84 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12796640 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7487477 [patent_doc_number] => 20110251138 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-13 [patent_title] => 'LIPOIC ACID METABOLITE CONJUGATE: PREPARATION AND THEIR THERAPEUTIC EFFECT' [patent_app_type] => utility [patent_app_number] => 12/796099 [patent_app_country] => US [patent_app_date] => 2010-06-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 5659 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0251/20110251138.pdf [firstpage_image] =>[orig_patent_app_number] => 12796099 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9140288 [patent_doc_number] => 08580749 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-11-12 [patent_title] => 'Peptide-coated cell localization to diseased or damaged tissues and methods related thereto' [patent_app_type] => utility [patent_app_number] => 12/795195 [patent_app_country] => US [patent_app_date] => 2010-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 30 [patent_no_of_words] => 12224 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12795195 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9046824 [patent_doc_number] => 08541378 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-09-24 [patent_title] => 'Recombinant albumins fused with poly-cysteine peptide and the methods for preparing the same' [patent_app_type] => utility [patent_app_number] => 12/792186 [patent_app_country] => US [patent_app_date] => 2010-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 5996 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12792186 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8995010 [patent_doc_number] => 08518894 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-08-27 [patent_title] => 'Human milk peptides' [patent_app_type] => utility [patent_app_number] => 13/375319 [patent_app_country] => US [patent_app_date] => 2010-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 9074 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 79 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13375319 [rel_patent_id] =>[rel_patent_doc_number] =>)